By means of “IV
133Xe method”, the utero-placental blood flow (UPBF) was measured in 38 cases in the 28 th to the 38 th week of pregnancy.In all cases the placental villi were detected to have been imbedded in the anterior wall of the uterus with the ultrasound Bscan. The scintillation detector was placed on the abdominal wall overlying this portion.From the recorded
133Xe wash-out curve, quick and slow components were obtained. The quick component reflected the fractional removal of the tracer from the intervillous blood pool while the slow component the removal from the myometrium. UPBF (
pF) was calculated by putting the value of the half life period (
pT½) obtained from the quick component into the equation:
pF=100×0.69/
pT½m
l/min/100g. On the other hand, the myometrial blood flow calculated by putting the value of the half life period (
mT½) derived from the slow component into the equation:
mF=70×0.69×
mT½m
l/min/100g. The “IV
133Xe method” is relatively simple and safe in humans. The radiation dose of 0.6 mCi of
133Xe is less than 1 mrad. Employing the ultrasound Bscan, the placenta was first located, and then the fetal biparietal diameter (BP-d) and the placental thickness were measured. The placental functions (urinary E
3 and HPL) were measured on the day of the
133Xe clearance measurements. The correlations between UPBF and the fetal BP-d, the placental thickness and the size of the newborn were studied, and the following results were obtained.
(1) UPBF in the 28 th to the 31 St gestational week was 68.4m
l/min/100g in average whereas in the 32 nd to the 35 th 68.7, and in the 36 th to the 39 th 66.0.Thus there were no significant differences according to the differences in the gestational week.The experience of the parity did not influence the results.
(2) The myometrial blood flow in the 28 th to the 31 th gestational week was 3.78m
l/mini 100g in average while in the 32 nd to the 35 th 4.39, and in the 36 th to the 39 th 4.55.Thus the differences in the gestational week did not affect the blood flow, nor did the experience of the parity.
(3) There were no significant correlations between E
3 or HPL and UPBF.
(4) No significant correlation was found between UPBF and the fetal BP-d.The thickness of the placenta, on the other hand, was significantly correlated with UPBF in the cases with the history of parities in all gestational weeks studied, but only in the 36 th to the 39 th gestational week in the cases without the history of parities.
(5) The weight, the height, the circumference of the chest and the Bp-d of the newborn were not significantly correlated with UPBF.
(6) The placental weight, area and ratio were measured after the delivery.These values were not significantly correlated with UPBF.
(7) The UPBF in a patient with the toxemia of pregnancy, Hashimoto disease, the scleroderma was measured in the 32nd gestational week. The value was lower than the rejection limit of the value of the normal subject. Soon after the measurement, the patient developed the fetal distress, resulting in a still-born. This case suggests a possible clinical application of the measurement of UPBF.
抄録全体を表示